Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
BIOA

BioAge Labs (BIOA) stock: insider trades, news & valuation

Heavy selling
Close · Oct 9, 2026 $6.34 +2.1% on the day +16.3% over 12 months 52-week range $5.11 – $25.10

Share price and insider trades

BIOA closeInsider buyInsider sale
0102030NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $95,514 on 2026-01-02 · Paul D RubinSold $139,369 on 2026-02-02 · Paul D RubinSold $150,890 on 2026-03-02 · Paul D RubinSold $157,084 on 2026-04-01 · Paul D RubinSold $216,000 on 2025-12-09 · Paul D RubinSold $509,241 on 2026-06-30 · Shane BartonSold $702,060 on 2025-12-04 · Paul D RubinSold $1,067,644 on 2026-06-29 · Shane BartonSold $4,755,743 on 2026-01-13 · Dov A Md Goldstein, Kristen Fortney
Bought, 12 months$0
Sold, 12 months$7.8M
Insiders buying0
Insiders selling4

BioAge Labs insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 4 sold $7.8M of BIOA stock on the open market.

BIOA insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $918K sold (2 trades)Q4 2025Q1 2026: $5.1M sold (8 trades)Q1 2026Q2 2026: $1.7M sold (3 trades)Q2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026—0$1.7M3
Q1 2026—0$5.1M8
Q4 2025—0$918K2

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day1.3×Last 5 sessions
Insiders' paper profit—On all tracked purchases —

Summary

Over the past 12 months, 0 BioAge Labs, Inc. insiders reported open-market purchases totaling $0, while 4 insiders reported sales totaling $7.8M. 13 of 13 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Jul 1SEC Shane BartonPrincipal Accounting Officer Sell Plan 42,350 $25.21 $1.1M -74.9% —
Jul 1SEC Shane BartonPrincipal Accounting Officer Sell Plan 20,216 $25.19 $509K -74.8% —
Apr 3SEC Paul D RubinChief Medical Officer Sell Plan 8,820 $17.81 $157K -64.4% —
Mar 3SEC Paul D RubinChief Medical Officer Sell Plan 7,433 $20.30 $151K -68.8% —
Feb 3SEC Paul D RubinChief Medical Officer Sell Plan 7,433 $18.75 $139K -66.2% —
Jan 15SEC Kristen FortneyCEO Sell Plan 233,107976,949 held (−19%) $18.12 $4.2M -65.0% —
Jan 15SEC Dov A Md GoldsteinCFO Sell Plan 11,66324,331 held (−32%) $20.54 $240K -69.1% —
Jan 15SEC Dov A Md GoldsteinCFO Sell Plan 8,97440,434 held (−18%) $18.43 $165K -65.6% —
Jan 15SEC Dov A Md GoldsteinCFO Sell Plan 4,44035,994 held (−11%) $19.45 $86K -67.4% —
Jan 15SEC Dov A Md GoldsteinCFO Sell Plan 1,92322,408 held (−8%) $21.08 $41K -69.9% —
Jan 6SEC Paul D RubinChief Medical Officer Sell Plan 7,433 $12.85 $96K -50.7% —
Dec 11SEC Paul D RubinChief Medical Officer Sell Plan 18,000 $12.00 $216K -47.2% —
Dec 5SEC Paul D RubinChief Medical Officer Sell Plan 68,897 $10.19 $702K -37.8% —

Insiders at BioAge Labs, Inc.

InsiderBoughtSoldLast filingScore
Kristen FortneyCEO — $4.2M Jan 15, 2026 —
Shane BartonPrincipal Accounting Officer — $1.6M Jul 1, 2026 —
Paul D RubinChief Medical Officer — $1.5M Apr 3, 2026 —
Dov A Md GoldsteinCFO — $532K Jan 15, 2026 —

BIOA stock: common questions

Are BioAge Labs, Inc. insiders buying BIOA stock?

In the past 12 months, 0 insiders reported open-market purchases of BIOA worth $0.

Are BioAge Labs, Inc. insiders selling BIOA stock?

4 insiders reported sales worth $7.8M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is BIOA's 52-week range?

Over the past year BIOA has traded between $5.11 and $25.10. It last closed at $6.34 on Oct 9, 2026.